{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:52Z","timestamp":1791828592649,"version":"4.3.4"},"reference-count":51,"publisher":"Consilium Medicum","issue":"8","license":[{"start":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T00:00:00Z","timestamp":1502755200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Glycogen storage disease (GSD) is an inherited metabolic disorder characterized by early childhood lipid metabolic disturbances with potentially proatherogenic effects. The review outlines the characteristics of impaired lipid composition and other changes in the cardiovascular system in GSD types I and III. It analyzes the factors enabling and inhibiting the development of atherosclerosis in patients with GSD. The review describes the paradox of vascular resistance to the development of early atherosclerosis despite the proatherogenic composition of lipids in the patients of this group.<\/jats:p>","DOI":"10.17116\/terarkh201789888-94","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T11:45:59Z","timestamp":1505389559000},"page":"88-94","source":"Crossref","is-referenced-by-count":1,"title":["Characteristics of lipid metabolism and the cardiovascular system in glycogenosis types I and III"],"prefix":"10.26442","volume":"89","author":[{"given":"N V","family":"Polenova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T V","family":"Strokova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A V","family":"Starodubova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18344","published-online":{"date-parts":[[2017,8,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"\u0421\u0443\u0440\u043a\u043e\u0432 \u0410.\u041d. \u0413\u043b\u0438\u043a\u043e\u0433\u0435\u043d\u043e\u0432\u0430\u044f \u0431\u043e\u043b\u0435\u0437\u043d\u044c \u0443 \u0434\u0435\u0442\u0435\u0439: \u0441\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u044b\u0435 \u043f\u0440\u0435\u0434\u0441\u0442\u0430\u0432\u043b\u0435\u043d\u0438\u044f (\u0447\u0430\u0441\u0442\u044c I). \u0412\u043e\u043f\u0440\u043e\u0441\u044b\u0441\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u043e\u0439\u043f\u0435\u0434\u0438\u0430\u0442\u0440\u0438\u0438. 2012;11(2):30-42. https:\/\/doi.org\/10.15690\/vsp.v11i2.208","DOI":"10.15690\/vsp.v11i2.208"},{"key":"ref2","unstructured":"\u041f\u043e\u0441\u0442\u0430\u043d\u043e\u0432\u043b\u0435\u043d\u0438\u0435 \u041f\u0440\u0430\u0432\u0438\u0442\u0435\u043b\u044c\u0441\u0442\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0439 \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u0438 \u043e\u0442 26.04.2012 \u2116403 \u00ab\u041e \u043f\u043e\u0440\u044f\u0434\u043a\u0435 \u0432\u0435\u0434\u0435\u043d\u0438\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u043b\u044c\u043d\u043e\u0433\u043e \u0440\u0435\u0433\u0438\u0441\u0442\u0440\u0430 \u043b\u0438\u0446, \u0441\u0442\u0440\u0430\u0434\u0430\u044e\u0449\u0438\u0445 \u0436\u0438\u0437\u043d\u0435\u0443\u0433\u0440\u043e\u0436\u0430\u044e\u0449\u0438\u043c\u0438 \u0438 \u0445\u0440\u043e\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u043c\u0438 \u043f\u0440\u043e\u0433\u0440\u0435\u0441\u0441\u0438\u0440\u0443\u044e\u0449\u0438\u043c\u0438 \u0440\u0435\u0434\u043a\u0438\u043c\u0438 (\u043e\u0440\u0444\u0430\u043d\u043d\u044b\u043c\u0438) \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u044f\u043c\u0438, \u043f\u0440\u0438\u0432\u043e\u0434\u044f\u0449\u0438\u043c\u0438 \u043a \u0441\u043e\u043a\u0440\u0430\u0449\u0435\u043d\u0438\u044e \u043f\u0440\u043e\u0434\u043e\u043b\u0436\u0438\u0442\u0435\u043b\u044c\u043d\u043e\u0441\u0442\u0438 \u0436\u0438\u0437\u043d\u0438 \u0433\u0440\u0430\u0436\u0434\u0430\u043d \u0438\u043b\u0438 \u0438\u0445 \u0438\u043d\u0432\u0430\u043b\u0438\u0434\u043d\u043e\u0441\u0442\u0438, \u0438 \u0435\u0433\u043e \u0440\u0435\u0433\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u043e\u0433\u043e \u0441\u0435\u0433\u043c\u0435\u043d\u0442\u0430\u00bb. http:\/\/base.garant.ru\/70168888\/"},{"key":"ref3","unstructured":"\u0421\u0443\u0441\u043f\u0438\u0446\u044b\u043d \u0415.\u041d., \u0421\u0442\u0440\u0435\u043a\u0430\u043b\u043e\u0432 \u0414.\u041b., \u042f\u043d\u0443\u0441 \u0413.\u0410.. \u0413\u0435\u043d\u0435\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u044f. \u041a\u0440\u0430\u0442\u043a\u0438\u0439 \u0441\u043f\u0440\u0430\u0432\u043e\u0447\u043d\u0438\u043a. \u0421\u041f\u0431.; 2015."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Ozen H. Glycogen storage diseases: new perspectives. World J. Gastroenterol. 2007;13(18):2541-2553. https:\/\/doi.org\/10.3748\/wjg.v13.i18.2541","DOI":"10.3748\/wjg.v13.i18.2541"},{"key":"ref5","unstructured":"\u0414\u0432\u043e\u0440\u044f\u043a\u043e\u0432\u0441\u043a\u0430\u044f \u0413.\u041c., \u0423\u0432\u0430\u0440\u043e\u0432\u0430 \u0415.\u0412., \u0414\u0432\u043e\u0440\u044f\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u0418.\u0412.. \u041e\u0446\u0435\u043d\u043a\u0430 \u044d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u043e\u0441\u0442\u0438 \u043b\u0435\u0447\u0435\u043d\u0438\u044f \u0433\u043b\u0438\u043a\u043e\u0433\u0435\u043d\u043e\u0437\u043e\u0432 \u043f\u043e \u0434\u0430\u043d\u043d\u044b\u043c \u0443\u043b\u044c\u0442\u0440\u0430\u0437\u0432\u0443\u043a\u043e\u0432\u043e\u0439 \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0438. \u0423\u043b\u044c\u0442\u0440\u0430\u0437\u0432\u0443\u043a\u043e\u0432\u0430\u044f \u0438 \u0444\u0443\u043d\u043a\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u0430\u044f \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0430. 2007;3:51-60."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"\u041a\u0440\u0430\u0441\u043d\u043e\u0432 \u041c.\u0412., \u041a\u0438\u0440\u0438\u043b\u043b\u043e\u0432 \u0410.\u0413., \u041a\u0440\u0430\u0441\u043d\u043e\u0432 \u0412.\u041c. \u041d\u0430\u0441\u043b\u0435\u0434\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u0435 \u0431\u043e\u043b\u0435\u0437\u043d\u0438 \u0443 \u0434\u0435\u0442\u0435\u0439. \u041f\u0440\u0430\u043a\u0442\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0430. 2009;7(39):22-30. http:\/\/pmarchive.ru\/nasledstvennye-bolezni-u-detej\/","DOI":"10.5922\/2223-2095-2009-1-1"},{"key":"ref7","unstructured":"Bhattacharya K. Investigation and management of the hepatic glycogen storage diseases. TransnarionalPediatrics. 2015;4(3):240-248. https:\/\/doi.org\/10.3978\/j.issn.2224-4336.2015.04.07"},{"key":"ref8","unstructured":"\u0421\u0442\u0440\u043e\u043a\u043e\u0432\u0430 \u0422.\u0412., \u041c\u0430\u0447\u0443\u043b\u0430\u043d \u0418.\u0412., \u041a\u0443\u0442\u044b\u0440\u0435\u0432\u0430 \u0415.\u041d. \u041a\u043b\u0438\u043d\u0438\u043a\u043e-\u043b\u0430\u0431\u043e\u0440\u0430\u0442\u043e\u0440\u043d\u044b\u0435 \u043f\u0440\u043e\u044f\u0432\u043b\u0435\u043d\u0438\u044f \u0433\u043b\u0438\u043a\u043e\u0433\u0435\u043d\u043e\u0432\u043e\u0439 \u0431\u043e\u043b\u0435\u0437\u043d\u0438 I \u0442\u0438\u043f\u0430 \u0443 \u0434\u0435\u0442\u0435\u0439 \u0440\u0430\u043d\u043d\u0435\u0433\u043e \u0432\u043e\u0437\u0440\u0430\u0441\u0442\u0430. \u0414\u043e\u043a\u0442\u043e\u0440.\u0440\u0443. 2013;9(87)."},{"key":"ref9","unstructured":"\u0415\u0444\u0440\u0435\u043c\u0435\u043d\u043a\u043e \u0418.\u0418. \u041d\u0430\u0441\u043b\u0435\u0434\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u0435 \u0431\u043e\u043b\u0435\u0437\u043d\u0438 \u0447\u0435\u043b\u043e\u0432\u0435\u043a\u0430: \u0441\u043f\u0440\u0430\u0432\u043e\u0447\u043d\u0438\u043a. \u0412\u0438\u0442\u0435\u0431\u0441\u043a: \u0423\u041e \u00ab\u0412\u0413\u0423 \u0438\u043c. \u041f.\u041c. \u041c\u0430\u0448\u0435\u0440\u043e\u0432\u0430\u00bb; 2012."},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Kalkan S, Coker M, S\u00f6zmen E. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III. Nutririon. Metabolism and cardiovascular disease. 2009;19(6):383-390. https:\/\/doi.org\/10.1016\/j.numecd.2008.09.005","DOI":"10.1016\/j.numecd.2008.09.005"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Kasakara CS, Cinasal G, Hasanoglu A. Endogenous glucose production from infancy to adulthood: a non-linear regression model. Arch Dis Child. 2014;1098-1102. https:\/\/doi.org\/10.1016\/S0300-595X(83)80051-6","DOI":"10.1136\/archdischild-2013-305718"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Priya S. Kishnani MD, Stephanie L. Austin MS, MA, Jose E. Abdenur MD Diagnosis and management of glycogen storage disease type I: a practice .guideline of the American College of Medical Genetics and Genomics Genetics in Medicine. 2014. https:\/\/doi.org\/10.1038\/gim.2014.128","DOI":"10.1038\/gim.2014.128"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Dietrich Matern, Hans Hermann Seydewitz, Deeksha Bali, Glycogen storage disease type I: diagnosis and phenotype\/genotype correlation. European Journal of Pediatrics. 2002;161(1):S10-S19. https:\/\/doi.org\/10.1007\/s00431-002-0998-5","DOI":"10.1007\/BF02679989"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Shin YS. Glycogen storage disease: clinical, biochemical, and molecular heterogeneity. SeminPediatrNeurol. 2006;13(2):115-120. https:\/\/doi.org\/10.1007\/s11845-013-0939-5","DOI":"10.1016\/j.spen.2006.06.007"},{"key":"ref15","unstructured":"\u0423\u0432\u0430\u0440\u043e\u0432\u0430 \u0415.\u0412. \u0422\u0435\u0447\u0435\u043d\u0438\u0435 \u0433\u043b\u0438\u043a\u043e\u0433\u0435\u043d\u043e\u0432\u043e\u0439 \u0431\u043e\u043b\u0435\u0437\u043d\u0438 \u043f\u0435\u0447\u0435\u043d\u0438 \u0443 \u0434\u0435\u0442\u0435\u0439 \u0432 \u0443\u0441\u043b\u043e\u0432\u0438\u044f\u0445 \u043a\u043e\u043c\u043f\u043b\u0435\u043a\u0441\u043d\u043e\u0439 \u0442\u0435\u0440\u0430\u043f\u0438\u0438: \u0410\u0432\u0442\u043e\u0440\u0435\u0444. \u0434\u0438\u0441. \u2026 \u043a\u0430\u043d\u0434. \u043c\u0435\u0434. \u043d\u0430\u0443\u043a. \u041c.; 2005. http:\/\/www.dissercat.com\/content\/techenie-glikogenovoi-bolezni-pecheni-u-detei-v-usloviyakh-kompleksnoi-terapii-0"},{"key":"ref16","unstructured":"\u0411\u0430\u0440\u0430\u043d\u043e\u0432 \u0410.\u0410. \u0424\u0435\u0434\u0435\u0440\u0430\u043b\u044c\u043d\u044b\u0435 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438 \u043f\u043e \u043e\u043a\u0430\u0437\u0430\u043d\u0438\u044e \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u043e\u0439 \u043f\u043e\u043c\u043e\u0449\u0438 \u0434\u0435\u0442\u044f\u043c \u0441 \u043f\u0435\u0447\u0435\u043d\u043e\u0447\u043d\u043e\u0439 \u0444\u043e\u0440\u043c\u043e\u0439 \u0433\u043b\u0438\u043a\u043e\u0433\u0435\u043d\u043e\u0432\u043e\u0439 \u0431\u043e\u043b\u0435\u0437\u043d\u0438 \u0423\u0442\u0432\u0435\u0440\u0436\u0434\u0435\u043d\u044b \u043d\u0430 XVIII \u041a\u043e\u043d\u0433\u0440\u0435\u0441\u0441\u0435 \u043f\u0435\u0434\u0438\u0430\u0442\u0440\u043e\u0432 \u0420\u043e\u0441\u0441\u0438\u0438 \u00ab\u0410\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u044b\u0435 \u043f\u0440\u043e\u0431\u043b\u0435\u043c\u044b \u043f\u0435\u0434\u0438\u0430\u0442\u0440\u0438\u0438\u00bb 14 \u0444\u0435\u0432\u0440\u0430\u043b\u044f 2015 \u0433. \u0438 \u043d\u0430 VII \u0421\u044a\u0435\u0437\u0434\u0435 \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0433\u043e \u043e\u0431\u0449\u0435\u0441\u0442\u0432\u0430 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0445 \u0433\u0435\u043d\u0435\u0442\u0438\u043a\u043e\u0432 19-23 \u043c\u0430\u044f 2015 \u0433. http:\/\/www.pediatr-russia.ru\/sites\/default\/files\/file\/kr_pfgb.pdf"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Talente G, Coleman R, Alter C et al. Glycocen storage disease in adults. Intern Med. 1994;120:218. http:\/\/annals.org\/aim\/article\/707084\/glycogen-storage-disease-adults","DOI":"10.7326\/0003-4819-120-3-199402010-00008"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Austin L, Proia A, Spencer-Manzon MJ. Cardiac Pathology in Glycogen Storage Disease Type III JIMD Reports \u2014 Case and Research Reports, 2012;6:65-72. https:\/\/doi.org\/10.1007\/8904_2011_118","DOI":"10.1007\/8904_2011_118"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Senocak F, Sarclar M, Ozkutlu S. Echocardiographic findings in some metabolic storage diseases. Jpn Heart J. 1994;35(5):635-643. https:\/\/doi.org\/10.1016\/j.cld.2004.06.009","DOI":"10.1536\/ihj.35.635"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Goeppert B, Lindner M, Vogel MN et al. Noncompoaction myocardium in association with type Ib glycogen storage disease. Pathol Res. 2012;208(10):620-622. https:\/\/doi.org\/10.1016\/j.prp.2012.06.007","DOI":"10.1016\/j.prp.2012.06.007"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Humbert M, Labrune Ph, Simonneau G. Severe pulmonary arterial hypertension in type 1 glycogen storage disease. European journal of pediatrics. 2002;161:93-96. https:\/\/doi.org\/10.1007\/s00431-002-1012-y","DOI":"10.1007\/s00431-002-1012-y"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Humbert M, Labrune P, Sitbon O. Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis. European respiratory journal. 2002;20:59-65. https:\/\/doi.org\/10.1183\/09031936.02.00258702","DOI":"10.1183\/09031936.02.00258702"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Terry GJ, Derks C, Rijn M. Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions. J Inherit Metab Dis. 2015;38:537-543. https:\/\/doi.org\/10.1007\/s10545-015-9811-2","DOI":"10.1007\/s10545-015-9811-2"},{"key":"ref24","unstructured":"\u041a\u0430\u0433\u0430\u043d\u043e\u0432 \u0411.\u0421. \u0414\u0435\u0442\u0441\u043a\u0430\u044f \u0433\u0435\u043f\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u044f. \u041c.: \u0418\u0437\u0434\u0430\u0442\u0435\u043b\u044c\u0441\u0442\u0432\u043e \u00ab\u0414\u0438\u043d\u0430\u0441\u0442\u0438\u044f\u00bb; 2009."},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Rake JP, Visser G, Labrune P et al. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr. 2002;161:S20-S34. https:\/\/doi.org\/10.1007\/s00431-002-0999-4","DOI":"10.1007\/BF02679990"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Greenea H, Swifta L, Howard R. Hyperlipidemia and fatty acid composition in patients treated for type IA glycogen storage disease. The Journal of Pediatrics. 1991;119(3):398-403. https:\/\/doi.org\/10.1016\/S0022-3476(05)82052-9","DOI":"10.1016\/S0022-3476(05)82052-9"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Fernandes J, Alaupovic P, Wit J. Gastric drip feeding in patients with glycogen storage disease type I: its effects on growth and plasma lipids and apolipoproteins. Pediatr Res. 1989;25:327-331. https:\/\/doi.org\/10.1203\/00006450-198904000-00002","DOI":"10.1203\/00006450-198904000-00002"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Rifkind B, Segal P. The Lipid Research Clinics Program Epidemiology Committee Plasma lipid distributions in selected North American populations: the Lipid Research Clinics Program Prevalence Study. American Journal of Epidemiology. 1990;131:32-47. https:\/\/doi.org\/10.1001\/jama.1983.03340140039025","DOI":"10.1001\/jama.1983.03340140039025"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Bandsma R., Prinsen B. Increased de novo Lipogenesis and Delayed Conversion of Large VLDL into Intermediate Density Lipoprotein Particles Contribute to Hyperlipidemia in Glycogen Storage Disease Type 1a. Pediatric Research. 2008;63(6):702-707. https:\/\/doi.org\/10.1203\/PDR.0b013e31816c9013","DOI":"10.1203\/PDR.0b013e31816c9013"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Sever S, Weinstein DA, Wolfsdorf J. Glycogen Storage Disease Type Ia: Linkage of Glucose, Glycogen, Lactic Acid, Triglyceride, and Uric Acid Metabolism. JClinLipidol. 2012;6(6):2-6. https:\/\/doi.org\/10.1016\/j.jacl.2012.08.005","DOI":"10.1016\/j.jacl.2012.08.005"},{"key":"ref31","unstructured":"\u0421\u0442\u0440\u043e\u0433\u0438\u0439 \u0412.\u0412. \u041d\u0430\u0440\u0443\u0448\u0435\u043d\u0438\u044f \u043b\u0438\u043f\u0438\u0434\u043d\u043e\u0433\u043e \u043e\u0431\u043c\u0435\u043d\u0430 \u0443 \u0434\u0435\u0442\u0435\u0439 \u0438 \u043f\u043e\u0434\u0440\u043e\u0441\u0442\u043a\u043e\u0432. \u041c\u0438\u043d\u0441\u043a: \u0411\u0413\u041c\u0423; 2009."},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Carvalho PM, Silva NJ, Dias PG. Glycogen Storage Disease type 1a \u2014 a secondary cause for hyperlipidemia: report of five cases. Journal of Diabetes and Metabolic Disoders. 2013;12-25. https:\/\/doi.org\/10.1186\/2251-6581-12-25","DOI":"10.1186\/2251-6581-12-25"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Bernier AV, Sentner CP, Correia CE. Hyperlipidemia in glycogen storage disease type III: Effect of age and metabolic control. J Inherit Metab Dis. 2008;31(6):729. https:\/\/doi.org\/10.1007\/s10545-008-0919-5","DOI":"10.1007\/s10545-008-0919-5"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"XH Li, QM Gong, Y Ling. Inherent lipid metabolic dysfunction in glycogen storage disease IIIa. Biochem Biophys Res Commun. 20145;455(1-2):90-97. https:\/\/doi.org\/10.1016\/j.bbrc.2014.10.096","DOI":"10.1016\/j.bbrc.2014.10.096"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Vivatrat N, Barshop BA, Jones KL. 2009. Severe hypertriglyceridemia and recurrent pancreatitis in a girl with type Ia glycogen storage disease and type III hyperlipoproteinemia. Am J Med Genet Part A. 149A:2557-2559. https:\/\/doi.org\/10.1002\/ajmg.a.33046","DOI":"10.1002\/ajmg.a.33046"},{"key":"ref36","unstructured":"\u0428\u0443\u043b\u044c\u043f\u0435\u043a\u043e\u0432\u0430 \u042e.\u041e. \u041f\u0430\u0442\u043e\u0433\u0435\u043d\u0435\u0442\u0438\u0447\u0435\u0441\u043a\u043e\u0435 \u0437\u043d\u0430\u0447\u0435\u043d\u0438\u0435 \u043b\u0438\u043f\u0438\u0434\u043e\u0432 \u043f\u0440\u0438 \u043d\u0435\u0430\u043b\u043a\u043e\u0433\u043e\u043b\u044c\u043d\u043e\u0439 \u0436\u0438\u0440\u043e\u0432\u043e\u0439 \u0431\u043e\u043b\u0435\u0437\u043d\u0438 \u043f\u0435\u0447\u0435\u043d\u0438. \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u0436\u0443\u0440\u043d\u0430\u043b \u0433\u0430\u0441\u0442\u0440\u043e\u044d\u043d\u0442\u0435\u0440\u043e\u043b\u043e\u0433\u0438\u0438, \u0433\u0435\u043f\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438, \u043a\u043e\u043b\u043e\u043f\u0440\u043e\u043a\u0442\u043e\u043b\u043e\u0433\u0438\u0438. 2012;1:45-56."},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"\u041b\u0430\u0432\u0440\u043e\u0432\u0430 \u0410.\u0415., \u0412\u0430\u0440\u043d\u0430\u0447\u0435\u0432\u0430 \u041b.\u041d., \u0428\u0430\u0431\u0443\u043d\u0438\u043d\u0430 \u0415.\u0418., \u041a\u043e\u043b\u0435\u0441\u043e\u0432 \u0421.\u0410., \u041a\u043e\u0440\u043a\u043e\u0442\u0430\u0448\u0432\u0438\u043b\u0438 \u041b.\u0412., \u0411\u044b\u0441\u0442\u0440\u0430\u043d\u043e\u0432\u0430 \u0414.\u0412., \u0414\u043c\u0438\u0442\u0440\u0438\u0435\u0432\u0430 \u0413.\u0412. \u041e\u0441\u043e\u0431\u0435\u043d\u043d\u043e\u0441\u0442\u0438 \u043d\u0430\u0440\u0443\u0448\u0435\u043d\u0438\u0439 \u043b\u0438\u043f\u0438\u0434\u043d\u043e\u0433\u043e \u043e\u0431\u043c\u0435\u043d\u0430 \u0443 \u0434\u0435\u0442\u0435\u0439 \u0441 \u0433\u0435\u043f\u0430\u0442\u043e\u0431\u0438\u043b\u0438\u0430\u0440\u043d\u043e\u0439 \u043f\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0435\u0439. \u0412\u043e\u043f\u0440\u043e\u0441\u044b c\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u043e\u0439 \u043f\u0435\u0434\u0438\u0430\u0442\u0440\u0438\u0438. 2014;13(2):107-111. https:\/\/doi.org\/10.15690\/vsp.v13i2.980","DOI":"10.15690\/vsp.v13i2.980"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Zhang P-Y, Xu X, Li X-C. Cardiovascular diseases: oxidative damage and antioxidant protection. Eur Rev Med Pharmacol Sci. 2014;18(20):3091-3096. https:\/\/doi.org\/10.1113\/expphysiol.1997.sp004024","DOI":"10.1113\/expphysiol.1997.sp004024"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Wittensteina B, Kleina M, Finckha B. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia. Free Radical Biology and Medicine. 2002; 33(1):103-110. https:\/\/doi.org\/10.1016\/S0891-5849(02)00863-8","DOI":"10.1016\/S0891-5849(02)00863-8"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Bernier AV, Correia CE, Haller MJ. Vascular Dysfunction in Glycogen Storage Disease Type I. Journal of pediatric. 2009;154(4);588-591. https:\/\/doi.org\/10.1016\/j.jpeds.2008.10.048","DOI":"10.1016\/j.jpeds.2008.10.048"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Ubels FL, Rake JP, Slaets JP et al. Is Glycogen storage disease Ia associated with atherosclerosis? Eur J Pediatr. 2002;161(1):62-62. https:\/\/doi.org\/10.1007\/BF02679997","DOI":"10.1007\/s00431-002-1006-9"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Robert HJ. Bandsma Jan-Peter Rake Increased lipogenesis and resistance of lipoproteins to oxidative modification in two patients with Glycogen Storage Disease type 1a Adapted from: Journal of Pediatrics. 2002;140:256-260. https:\/\/doi.org\/10.1067\/mpd.2002.121382","DOI":"10.1067\/mpd.2002.121382"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Goulart JM, Yoo JY, Kirchoff-Torres KF et al. Ischemic stroke in an adult with glycogen storage disease type I. J Clin Neurosci. 2010;17:1467-1469. https:\/\/doi.org\/10.1016\/j.jocn.2010.03.026","DOI":"10.1016\/j.jocn.2010.03.026"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Boudjemline AM, Petit F, Buron A. Glycogen storage disease type I (GSD I). AtlasGenetCytogenetOncolHaematol. 2012;16(11):860-863. https:\/\/doi.org\/10.4267\/2042\/48238","DOI":"10.4267\/2042\/48238"},{"key":"ref45","unstructured":"\u0414\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0430 \u0438 \u043a\u043e\u0440\u0440\u0435\u043a\u0446\u0438\u044f \u043d\u0430\u0440\u0443\u0448\u0435\u043d\u0438\u0439 \u043b\u0438\u043f\u0438\u0434\u043d\u043e\u0433\u043e \u043e\u0431\u043c\u0435\u043d\u0430 \u0441 \u0446\u0435\u043b\u044c\u044e \u043f\u0440\u043e\u0444\u0438\u043b\u0430\u043a\u0442\u0438\u043a\u0438 \u0438 \u043b\u0435\u0447\u0435\u043d\u0438\u044f \u0430\u0442\u0435\u0440\u043e\u0441\u043a\u043b\u0435\u0440\u043e\u0437\u0430 \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438 V \u043f\u0435\u0440\u0435\u0441\u043c\u043e\u0442\u0440. \u041d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u043e\u0435 \u043e\u0431\u0449\u0435\u0441\u0442\u0432\u043e \u043f\u043e \u0438\u0437\u0443\u0447\u0435\u043d\u0438\u044e \u0430\u0442\u0435\u0440\u043e\u0441\u043a\u043b\u0435\u0440\u043e\u0437\u0430 (\u041d\u041e\u0410), \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0435 \u043a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u043e\u0435 \u043e\u0431\u0449\u0435\u0441\u0442\u0432\u043e (\u0420\u041a\u041e) \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0435 \u043e\u0431\u0449\u0435\u0441\u0442\u0432\u043e \u043a\u0430\u0440\u0434\u0438\u043e\u0441\u043e\u043c\u0430\u0442\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0440\u0435\u0430\u0431\u0438\u043b\u0438\u0442\u0430\u0446\u0438\u0438 \u0438 \u0432\u0442\u043e\u0440\u0438\u0447\u043d\u043e\u0439 \u043f\u0440\u043e\u0444\u0438\u043b\u0430\u043a\u0442\u0438\u043a\u0438 (\u0420\u043e\u0441\u041e\u041a\u0420). \u041c\u043e\u0441\u043a\u0432\u0430 2012 \u0433\u043e\u0434. http:\/\/www.scardio.ru\/content\/Guidelines\/rek_lipid_2012.pdf"},{"key":"ref46","unstructured":"Yekeler E, Dursun M, Emeksiz E. Prediction of premature atherosclerosis by endothelial dysfunction and increased intima-media thickness in glycogen storage disease types Ia and III. The Turkish Journal of Pediatrics. 2007;49:115-129. http:\/\/search.proquest.com\/openview\/b9174aa2ad8da3597ef4803aa87fd642\/1?pq-origsite=gscholar"},{"key":"ref47","unstructured":"Rake F, Slaets J. Hyperlipidaemia and atherosclerosis in Glycogen Storage Disease type I. Eur J Pediatr. 2002;160:62-64. http:\/\/www.rug.nl\/research\/portal\/files\/3014583\/c5.pdf"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Muhlhausen C, Schneppenheim R, Budde U, et al. Decreased plasma concentration of von Willebrand factor antigen in patients with glycogen storage disease type Ia. J Inherit Metab Dis. 2005;28:945-950. https:\/\/doi.org\/10.1007\/s10545-005-0184-9","DOI":"10.1007\/s10545-005-0184-9"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-126. https:\/\/doi.org\/10.1056\/NEJM199901143400207","DOI":"10.1056\/NEJM199901143400207"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Tamaki M, Tamura Y, Ogihara T. Lack of evident atherosclerosis despite multiple risk factors in glycogen storage disease type 1a with hyperadiponectinemia. Metabolism clinical and experimental. 2007; 10:1402-1404. https:\/\/doi.org\/10.1016\/j.metabol.2007.06.002","DOI":"10.1016\/j.metabol.2007.06.002"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Lee PJ, Celermajer, DS, Robinson et al. Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a. Atherosclerosis. 1994;110:95-100. https:\/\/doi.org\/10.1016\/0021-9150(94)90072-8","DOI":"10.1016\/0021-9150(94)90072-8"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/32324\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/32324\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T11:21:16Z","timestamp":1634124076000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/32324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,15]]},"references-count":51,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,15]]}},"URL":"https:\/\/doi.org\/10.17116\/terarkh201789888-94","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8,15]]}}}